SEC Form 4 · accession 0001209191-15-079896
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
Nov 12, 2015
Accepted (ET)
Nov 12, 2015 · 7:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 12, 2015 | M | 20,000 | $1.51 | A | 1,598,396 | I | James N. Wilson and Pamela D. Wilson Trust |
| Common stockF1 | Nov 12, 2015 | S | 20,000 | $4.90 | D | 1,578,396 | I | James N. Wilson and Pamela D. Wilson Trust |
| Common stockF2 | Nov 12, 2015 | S$0 | 0 | $0.00 | D | 901,067 | I | James and Pamela Wilson Family Partners |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF3 | $1.51 | Nov 12, 2015 | M | 20,000 | D | — | May 18, 2017 | Common stock | 20,000 | 170,000 | D |
Explanation of responses
- F1Represents the weighted average sale price for the entire number of shares sold.
- F2Not applicable as the line item was included to show all other indirect holdings of the Reporting Person.
- F3Fully exerciseable.